The S&P 500 Index remains in a bull market and is trading at a record high, driven by numerous catalysts: strong corporate earnings and investors moving past the Iran war, mirroring their response to the Ukraine war. It ended last week at $7,473, and continued the uptrend on RWA platforms like Hyperliquid and Ondo. Here… Continue reading S&P 500 Index, VOO, SPY, and IVV: Key catalysts to watch this week
stocktrader
WTI and Brent crude crashes on Hyperliquid as Trump announces Iran deal
WTI and Brent crude oil prices crashed on Hyperliquid after President Donald Trump announced that the US and Iran had reached an agreement to reopen the Strait of Hormuz. The West Texas Intermediate plunged to $89, while Brent, the global benchmark, plunged to $93. Trump announces deal to reopen Strait of Hormuz Most market participants… Continue reading WTI and Brent crude crashes on Hyperliquid as Trump announces Iran deal
Fears and frenzy mount as SpaceX, OpenAI and Anthropic prepare for a $4T AI IPO wave
Silicon Valley is heading toward what could become one of the most consequential listing waves in modern market history, with artificial intelligence heavyweights SpaceX, OpenAI, and Anthropic preparing to enter public markets at valuations that could redraw the hierarchy of global corporations. After several subdued years for technology listings, the expected debuts of the three… Continue reading Fears and frenzy mount as SpaceX, OpenAI and Anthropic prepare for a $4T AI IPO wave
These three stocks are must-own ahead of the SpaceX IPO
As the global financial community eagerly awaits SpaceX’s historic initial public offering (IPO) – rumoured to command some $1.7 trillion valuation on June 12 – a wave of capital is flooding into public space stocks. This unprecedented offering promises to shine a “blinding spotlight” on the entire commercial space ecosystem, resetting industry benchmarks and driving… Continue reading These three stocks are must-own ahead of the SpaceX IPO
Dow hits record high as easing yields lift Wall Street
Wall Street closed higher on Friday, with the Dow Jones Industrial Average reaching an intraday record high, as easing Treasury yields and optimism surrounding diplomatic efforts in the Middle East supported investor sentiment heading into the Memorial Day holiday weekend. The Dow gained nearly 295 points, or 0.59%, to close at approximately 50,580. The blue-chip… Continue reading Dow hits record high as easing yields lift Wall Street
Generac stock jumps 9%: Why is Jefferies bullish on the stock?
Shares of Generac Holdings (GNRC) surged on Friday after Jefferies upgraded the backup power equipment maker, citing growing momentum in AI-driven data center infrastructure demand and increasing traction for the company’s Baudouin engines among hyperscale operators. Generac shares climbed 9% after Jefferies raised its rating on the stock to Buy from Hold and increased its… Continue reading Generac stock jumps 9%: Why is Jefferies bullish on the stock?
Take-Two stock falls as weak FY27 guidance offsets GTA VI hype
Shares of Take-Two Interactive Software (TTWO) fell on Friday despite the video game publisher reporting better-than-expected quarterly results and reaffirming the release timeline for the highly anticipated Grand Theft Auto VI. The company posted stronger-than-expected fiscal fourth-quarter net bookings and a narrower loss than analysts anticipated. However, investor sentiment weakened after Take-Two issued fiscal 2027… Continue reading Take-Two stock falls as weak FY27 guidance offsets GTA VI hype
Dell stock rallies as analysts show love ahead of Q1 earnings
Dell Technologies (DELL) ripped higher on Friday as a series of analyst upgrades and price target hikes fuelled intense buying momentum ahead of the firm’s Q1 earnings set to be released on May 28th. Wall Street remains convinced that DELL will report blockbuster financials for the first quarter, with revenue coming in up nearly… Continue reading Dell stock rallies as analysts show love ahead of Q1 earnings
Merck stock jumps as Keytruda combo trials boost cancer pipeline
Shares of Merck & Co. (MRK) rose 5% on Friday after the pharmaceutical giant reported positive developments across multiple oncology programs, reinforcing investor confidence in its efforts to extend the dominance of blockbuster cancer drug Keytruda ahead of looming patent expirations later this decade. The rally followed encouraging Phase 3 clinical trial results involving sacituzumab… Continue reading Merck stock jumps as Keytruda combo trials boost cancer pipeline